News

Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the initial

The agreement formalizes the working relationship between ScripsAmerica and RapiMed’s manufacturer. Both the firms have been working together and just completed ScripsAmerica’s first order ticketed for Hong Kong

The acquisition of Idenix is expected to expand Merck’s portfolio of investigational therapies for hepatitis C. Merck Research Laboratories president Roger Perlmutter said Idenix has established a promising

Onychomycosis is a common and destructive nail infection that is currently undertreated due to the limitations of available treatments. At present, over-the-counter (OTC) or prescription topical treatments provide

The new indication reflects that AZILECT can be used alone or in combination with other Parkinson’s disease (PD) medications. The approval reinforces the growing clinical evidence demonstrating the

The vaccine is a "therapeutic vaccine" in that it will be used to stimulate the immune system of patients that already suffer from cancer. This is in contrast

Pursuant to this agreement, CELLforCURE will be responsible for the manufacturing of cGMP clinical batches for candidates from Cellectis’ UCART product family. The candidates from UCART (for Universal

Pursuant to this certificate, the USPTO has extended the term of US patent No. 5,861,379 (tesamorelin composition of matter patent) by five years. This patent was originally set

The trial is designed to characterize the safety, tolerability, pharmacokinetics and pharmacodynamics of increasing doses of AG-348 for 14 days. AG-348 is a first-in-class, orally available activator of